Journal of Nuclear Medicine Technology June 2026, jnmt.126.272186; DOI: https://doi.org/10.2967/jnmt.126.272186 ...
Myocardial perfusion scintigraphy and 2-dimensional (2D) echocardiography are used for evaluating left ventricular function and ejection fraction (EF). This study aimed to validate the ...
Journal of Nuclear Medicine Technology June 2026, jnmt.125.270840; DOI: https://doi.org/10.2967/jnmt.125.270840 ...
Journal of Nuclear Medicine Technology June 2026, jnmt.126.272275; DOI: https://doi.org/10.2967/jnmt.126.272275 ...
Journal of Nuclear Medicine Technology June 2026, jnmt.125.271591; DOI: https://doi.org/10.2967/jnmt.125.271591 ...
Key terminology related to theranostics in prostate cancer has been consolidated into concise reference tables. The definitions are simplified to emphasize practical clinical understanding and working ...
Prostate-specific membrane antigen (PSMA) has fundamentally reshaped prostate cancer imaging and therapy, delivering an unprecedented combination of high lesion conspicuity, broad clinical ...
Prostate cancer is a rapidly expanding area for radiopharmaceutical therapy, primarily driven by prostate-specific membrane antigen–targeted imaging and therapy. This growth necessitates new workflows ...
Journal of Nuclear Medicine Technology April 2026, jnmt.125.271114; DOI: https://doi.org/10.2967/jnmt.125.271114 ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272024; DOI: https://doi.org/10.2967/jnmt.126.272024 ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272276; DOI: https://doi.org/10.2967/jnmt.126.272276 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results